Perbedaan Merck Tbk. dan Royal Prima Tbk.: Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb), sedangkan Royal Prima Tbk. diperdagangkan di Rp93 (kapitalisasi pasar 318,98 M, volume 24 jam 6,3 jt). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 5,3× kapitalisasi pasar Royal Prima Tbk., dan Royal Prima Tbk. lebih aktif diperdagangkan (6,3 jt vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MERK | PRIM | |
|---|---|---|
Kapitalisasi Pasar | 1,7 T | 318,98 M |
Volume | 37,6 rb | 6,3 jt |
Lot | 376 | 62,95 rb |
Perputaran | 144,47 jt | 590,85 jt |
Harga Rata-rata | 3.842,23 | 93,86 |
Nilai Transaksi | 144,47 jt | 590,85 jt |
Harga Ekuilibrium Indikatif | 3.840 | 93 |
Volume Ekuilibrium Indikatif | 7 | 1,83 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →PT Royal Prima (the Company) was established based on notarial deed No. 1 dated 4 June 2013 of Heriyanti, S.H., M.Kn., notary in Medan.
Selengkapnya di halaman PRIM →